
Todos Medical Ltd. – OTC:TOMDF
Todos Medical Ltd. stock price today
Todos Medical Ltd. stock price monthly change
Todos Medical Ltd. stock price quarterly change
Todos Medical Ltd. stock price yearly change
Todos Medical Ltd. key metrics
Market Cap | 6.75M |
Enterprise value | 37.47M |
P/E | -0.03 |
EV/Sales | 3.48 |
EV/EBITDA | -2.24 |
Price/Sales | 0.15 |
Price/Book | -0.05 |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | -100% |
Revenue Y/Y | -86.94% |
Profit margin | -360.67% |
Oper. margin | -30.65% |
Gross margin | 41.66% |
EBIT margin | -30.65% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTodos Medical Ltd. stock price history
Todos Medical Ltd. stock forecast
Todos Medical Ltd. financial statements
Dec 2022 | 1.40M | -4.99M | -355.88% |
---|---|---|---|
Mar 2023 | 0 | 0 | |
Jun 2023 | 0 | 0 | |
Sep 2023 | 0 | 0 |
Sep 2022 | 14227000 | 44.86M | 315.33% |
---|---|---|---|
Mar 2023 | 0 | 0 | |
Jun 2023 | 0 | 0 | |
Sep 2023 | 0 | 0 |
Dec 2022 | -796.96K | 12.31K | 763.4K |
---|---|---|---|
Mar 2023 | 0 | 0 | 0 |
Jun 2023 | 0 | 0 | 0 |
Sep 2023 | 0 | 0 | 0 |
Todos Medical Ltd. alternative data
Aug 2023 | 7 |
---|---|
Sep 2023 | 7 |
Oct 2023 | 7 |
Nov 2023 | 7 |
Dec 2023 | 7 |
Jan 2024 | 7 |
Feb 2024 | 7 |
Mar 2024 | 7 |
Apr 2024 | 7 |
May 2024 | 7 |
Jun 2024 | 7 |
Jul 2024 | 7 |
Todos Medical Ltd. other data
Period | Buy | Sel |
---|---|---|
Aug 2022 | 1000000 | 0 |
Mar 2023 | 5000000 | 0 |
Insider | Compensation |
---|---|
Mr. Gerald E. Commissiong (1983) Chief Executive Officer, Pres & Director | $183,330 |
Mr. Daniel Hirsch (1969) Chief Financial Officer & Director | $120,830 |
-
What's the price of Todos Medical Ltd. stock today?
One share of Todos Medical Ltd. stock can currently be purchased for approximately $0.
-
When is Todos Medical Ltd.'s next earnings date?
Unfortunately, Todos Medical Ltd.'s (TOMDF) next earnings date is currently unknown.
-
Does Todos Medical Ltd. pay dividends?
No, Todos Medical Ltd. does not pay dividends.
-
How much money does Todos Medical Ltd. make?
Todos Medical Ltd. has a market capitalization of 6.75M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 37.08% to 7.7M US dollars.
-
What is Todos Medical Ltd.'s stock symbol?
Todos Medical Ltd. is traded on the OTC under the ticker symbol "TOMDF".
-
What is Todos Medical Ltd.'s primary industry?
Company operates in the Healthcare sector and Diagnostics & Research industry.
-
How do i buy shares of Todos Medical Ltd.?
Shares of Todos Medical Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Todos Medical Ltd.'s key executives?
Todos Medical Ltd.'s management team includes the following people:
- Mr. Gerald E. Commissiong Chief Executive Officer, Pres & Director(age: 42, pay: $183,330)
- Mr. Daniel Hirsch Chief Financial Officer & Director(age: 56, pay: $120,830)
-
How many employees does Todos Medical Ltd. have?
As Jul 2024, Todos Medical Ltd. employs 7 workers.
-
When Todos Medical Ltd. went public?
Todos Medical Ltd. is publicly traded company for more then 8 years since IPO on 24 Aug 2017.
-
What is Todos Medical Ltd.'s official website?
The official website for Todos Medical Ltd. is todosmedical.com.
-
How can i contact Todos Medical Ltd.?
Todos Medical Ltd. can be reached via phone at +972 52 642 0126.
Todos Medical Ltd. company profile:

Todos Medical Ltd.
todosmedical.comOTC
7
Diagnostics & Research
Healthcare
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.
Rehovot, 6701203
CIK: 0001645260
ISIN: IL0011392375
: